All Stories

  1. Integrating clinical scenarios in undergraduate anatomy teaching to enhance student engagement: A three‐year exploratory study in a small pre‐medicine cohort
  2. Correction: Thomas Broome, S.; Castorina, A. Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice. Biomedicines 2022, 10, 3174
  3. PAC1 Receptor Knockout Mice Reveal Critical Links Between ER Stress, Myelin Homeostasis, and Neurodegeneration
  4. Optimum heat reflux extraction of key bioactive compounds from lemon scented tea tree ( Leptospermum petersonii) leaves and their cytotoxic effects
  5. A Standard Operating Procedure for Dual-Task Training to Improve Physical and Cognitive Function in Older Adults: A Scoping Review
  6. VPAC1 and VPAC2 Receptor Heterozygosity Confers Distinct Biological Properties to BV2 Microglial Cells
  7. Increased Expression of the Neuropeptides PACAP/VIP in the Brain of Mice with CNS Targeted Production of IL-6 Is Mediated in Part by Trans-Signalling
  8. Differential Expression of PACAP/VIP Receptors in the Post-Mortem CNS White Matter of Multiple Sclerosis Donors
  9. Understanding Body Types and Physical Fitness in Young Professional Soccer Players
  10. Targeting the PAC1 receptor mitigates degradation of myelin and synaptic markers and diminishes locomotor deficits in the cuprizone demyelination model
  11. Small Extracellular Vesicle-Derived Circular RNA hsa_circ_0007386 as a Biomarker for the Diagnosis of Pleural Mesothelioma
  12. Adapted Physical Activity Programs for Children with Autism Spectrum Disorder and Neurotypical Children: Differences between Online and Face-to-Face Training
  13. Hippocampal neuroinflammation causes sex-specific disruptions in instrumental conditioning, Pavlovian approach, and neuronal excitation
  14. The Neuroanatomy of the Habenular Complex and Its Role in the Regulation of Affective Behaviors
  15. Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress—Relevance to Multiple Sclerosis Pathophysiology
  16. An Overview of Physical Exercise Program Protocols and Effects on the Physical Function in Multiple Sclerosis: An Umbrella Review
  17. Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
  18. Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus
  19. L-Proline Prevents Endoplasmic Reticulum Stress in Microglial Cells Exposed to L-azetidine-2-carboxylic Acid
  20. Identification of Key Genes and Regulatory Pathways in Multiple Sclerosis Brain Samples: A Meta-Analysis of Micro-Array Datasets
  21. Molecular Assessment of Healthy Pathological Articular Cartilages in Physically Active People: A Scoping Review
  22. Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice
  23. Pro-Inflammatory and Pro-Apoptotic Effects of the Non-Protein Amino Acid L-Azetidine-2-Carboxylic Acid in BV2 Microglial Cells
  24. Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington’s Disease
  25. Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
  26. PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
  27. The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
  28. Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury
  29. Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet
  30. The role of exercise on peripheral nerve regeneration: from animal model to clinical application
  31. PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
  32. PACAP and VIP Modulate LPS-induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
  33. Doxycycline and Minocycline Act as Positive Allosteric Modulators of the PAC1 Receptor and Induce Plasminogen Activators in RT4 Schwann Cells
  34. Doxycycline and Minocycline act as Positive Allosteric Modulators of the PAC1 Receptor and Induce Plasminogen Activators in RT4 Schwann Cells
  35. Neuroprotective Effects of Physical Activity via the Adaptation of Astrocytes
  36. Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells
  37. Brain CHID1 Expression Correlates with NRGN and CALB1 in Healthy Subjects and AD Patients
  38. Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson’s Disease
  39. Evaluation of a Cell-Free Collagen Type I-Based Scaffold for Articular Cartilage Regeneration in an Orthotopic Rat Model
  40. Dopamine: an immune transmitter
  41. Moderate Physical Activity as a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological Key
  42. A correlation between intestinal microbiota dysbiosis and osteoarthritis
  43. Dopaminergic-GABAergic interplay and alcohol binge drinking
  44. PACAP and VIP expression in the periaqueductal grey of the rat following sciatic nerve constriction injury
  45. Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System
  46. Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis
  47. The “Journal of Functional Morphology and Kinesiology” Journal Club Series: Highlights on Recent Papers in Musculoskeletal Disorders
  48. Angiogenesis correlates with macrophage and mast cell infiltration in lung tissue of animals exposed to fluoro-edenite fibers
  49. Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution
  50. Enhanced expression of CD31/platelet endothelial cell adhesion molecule 1 (PECAM1) correlates with hypoxia inducible factor-1 alpha (HIF-1α) in human glioblastoma multiforme
  51. Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam
  52. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme
  53. Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis
  54. PACAP Interacts with PAC1 Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures
  55. The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer′s disease: agonists or antagonists?
  56. Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?
  57. Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications
  58. Aluminum alters cellular defense response to amyloid beta in neuronal cells
  59. Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate
  60. Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone
  61. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: Involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways
  62. Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death
  63. Increased Hippocampal CREB Phosphorylation in Dopamine D3 Receptor Knockout Mice Following Passive Avoidance Conditioning
  64. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus
  65. Antiproliferative Effects of PACAP and VIP in Serum-Starved Glioma Cells
  66. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction
  67. Hippocampal Neurofibromin and Amyloid Precursor Protein Expression in Dopamine D3 Receptor Knock-out Mice Following Passive Avoidance Conditioning
  68. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats
  69. Involvement of PACAP/ADNP Signaling in the Resistance to Cell Death in Malignant Peripheral Nerve Sheath Tumor (MPNST) Cells
  70. Dopamine-3 receptor modulates intraocular pressure: Implications for glaucoma
  71. Epidermal growth factor receptor (EGFR) and neuregulin (Neu) activation in human airway epithelial cells exposed to nickel acetate
  72. Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death
  73. Neurofibromin and Amyloid Precursor Protein Expression in Dopamine D3 Receptor Knock-Out Mice Brains
  74. Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells
  75. PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells
  76. Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of ß-amyloid toxicity
  77. PACAP and VIP prevent apoptosis in schwannoma cells
  78. Parkin Expression Profile in Dopamine D3 Receptor Knock-Out Mice Brains
  79. Expression profile of ErbB receptor’s family in human alveolar type 2-like cell line A549 exposed to hexavalent chromium